Supernus Pharmaceuticals
SUPN
#4217
Rank
NZ$4.81 B
Marketcap
NZ$82.93
Share price
2.25%
Change (1 day)
48.07%
Change (1 year)

Market capitalization of Supernus Pharmaceuticals (SUPN)

Market cap: NZ$4.81 Billion

As of May 2026 Supernus Pharmaceuticals has a market cap of NZ$4.81 Billion. This makes Supernus Pharmaceuticals the world's 4217th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Supernus Pharmaceuticals from 2012 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$4.81 B-5.72%
2025NZ$5.10 B40.25%
2024NZ$3.64 B45.61%
2023NZ$2.50 B-17.68%
2022NZ$3.03 B33.77%
2021NZ$2.27 B23.15%
2020NZ$1.84 B-0.36%
2019NZ$1.85 B-28.59%
2018NZ$2.59 B-9.92%
2017NZ$2.87 B59.28%
2016NZ$1.80 B87.65%
2015NZ$0.96 B111.39%
2014NZ$0.45 B24.09%
2013NZ$0.36 B37.46%
2012NZ$0.26 B

End of Day market cap according to different sources

On May 19th, 2026 the market cap of Supernus Pharmaceuticals was reported to be:

NZ$4.70 Billion
by Nasdaq info icon info icon
NZ$4.70 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
NZ$940.26 B 19,434.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$262.20 B 5,347.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$1.547 T 32,050.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$203.61 B 4,130.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Zogenix
ZGNX
NZ$2.55 B-46.91%๐Ÿ‡บ๐Ÿ‡ธ USA
United Therapeutics
UTHR
NZ$40.77 B 747.04%๐Ÿ‡บ๐Ÿ‡ธ USA